A 3-Year MBSAQIP propensity-matched analysis of Roux-en-Y gastric bypass with concomitant cholecystectomy: Is the robotic or laparoscopic approach preferred?
Bariatric
Biliary disease
Concomitant cholecystectomy
Laparoscopic
Robotic
Roux-en-y gastric bypass
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
25
05
2020
accepted:
25
08
2020
pubmed:
23
9
2020
medline:
21
10
2021
entrez:
22
9
2020
Statut:
ppublish
Résumé
The primary objective of this study was to compare outcomes of patients undergoing minimally invasive RYGB (MIS/RYGB) versus MIS/RYGB with concomitant Cholecystectomy (CCY). A secondary objective was to compare the outcomes for laparoscopic RYGB (LRYGB) and robotic RYGB (RRYGB) with concomitant CCY. Outcomes of 117,939 MIS/RYGB with and without CCY were propensity-matched (Age, Gender, BMI, Comorbidities), 10:1, using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database from 2015-2017. The MIS/RYGB with CCY were then separated into LRYGB and RRYGB cases for comparison. Exclusion criteria included emergency cases, conversions to open, and age less than 18. The operative time and length of stay (LOS) was significantly increased with addition of concomitant CCY. There was no significant difference in readmission, reoperation, intervention, morbidity, or mortality. The RRYGB with CCY approach was associated with a significantly longer operative times compared to the LRYGB with CCY (177 vs. 135 min, p < 0.0001). The laparoscopic and robotic groups demonstrated no significant difference LOS, readmission, reoperation, intervention, morbidity, or mortality rates. Our study demonstrates that concomitant cholecystectomy increased the operative time and length of stay. However, concomitant CCY was not associated with any increased morbidity. The study demonstrated no significant difference in morbidity between robotic and laparoscopic approach. The robotic approach, however, was associated with a significantly longer operative time compared to the laparoscopic approach. While the indications for CCY remain controversial, concomitant CCY does not convey additional risk regardless of operative approach.
Sections du résumé
BACKGROUND
The primary objective of this study was to compare outcomes of patients undergoing minimally invasive RYGB (MIS/RYGB) versus MIS/RYGB with concomitant Cholecystectomy (CCY). A secondary objective was to compare the outcomes for laparoscopic RYGB (LRYGB) and robotic RYGB (RRYGB) with concomitant CCY.
METHODS
Outcomes of 117,939 MIS/RYGB with and without CCY were propensity-matched (Age, Gender, BMI, Comorbidities), 10:1, using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database from 2015-2017. The MIS/RYGB with CCY were then separated into LRYGB and RRYGB cases for comparison. Exclusion criteria included emergency cases, conversions to open, and age less than 18.
RESULTS
The operative time and length of stay (LOS) was significantly increased with addition of concomitant CCY. There was no significant difference in readmission, reoperation, intervention, morbidity, or mortality. The RRYGB with CCY approach was associated with a significantly longer operative times compared to the LRYGB with CCY (177 vs. 135 min, p < 0.0001). The laparoscopic and robotic groups demonstrated no significant difference LOS, readmission, reoperation, intervention, morbidity, or mortality rates.
CONCLUSIONS
Our study demonstrates that concomitant cholecystectomy increased the operative time and length of stay. However, concomitant CCY was not associated with any increased morbidity. The study demonstrated no significant difference in morbidity between robotic and laparoscopic approach. The robotic approach, however, was associated with a significantly longer operative time compared to the laparoscopic approach. While the indications for CCY remain controversial, concomitant CCY does not convey additional risk regardless of operative approach.
Identifiants
pubmed: 32959181
doi: 10.1007/s00464-020-07939-0
pii: 10.1007/s00464-020-07939-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4712-4718Références
Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC (2005) Effect of Estrogen therapy on gallbladder disease. JAMA 293:330–339
doi: 10.1001/jama.293.3.330
Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Duartez P (2009) Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 23(7):1645–1645
doi: 10.1007/s00464-009-0445-z
Everhart JE (1993) Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 119(10):1029–1035
doi: 10.7326/0003-4819-119-10-199311150-00010
Adami Chaim E, da Silva BB, de Oliveira C (2003) Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg 13(4):625–628
doi: 10.1381/096089203322190862
Wanjura V, Sandblom G, Oasterberg J, Enochsson L, Ottosson J, Szabo E (2017) Cholecystectomy after Gastric Bypass—Incidence and Complications. Sug Obes Relat Dis. 13(4):979–987
doi: 10.1016/j.soard.2016.12.004
Shiffman ML, Sugerman HJ, Kellum JM, Moore EW (1992) Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology 103(1):214–221
doi: 10.1016/0016-5085(92)91115-K
Worni M, Guller U, Shah A, Mihir G, Shah J, Rajgor D, Pietrobon R, Jacobs DO, Ostbye T (2011) Cholecystectomy Concomitant with Laparoscopic Gastric Bypass: A Trend Analysis of the Nationwide Inpatient Sample from 2001 to 2008. Obes Surg 22(2):220–229
doi: 10.1007/s11695-011-0575-y
Leyva-Alvizo A, Arredondo-Saldaña G, Leal-Isla-Flores V et al (2020) Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery. Surg Obes Relat Dis. 16(1):158–164. https://doi.org/10.1016/j.soard.2019.10.016
doi: 10.1016/j.soard.2019.10.016
pubmed: 31839526
EE, Mason (2002) Gallbladder management in obesity surgery. Obes Surg, 222–229.
Robert B. Dorman, Wei Zhong, Anasooya A Abraham, Sayeed Ikramuddin, Waddah B. Al-Refaie, Daniel B. Leslie, Elizabeth B. Habermann (2013) Does Concomitant Cholecystectomy at Time of Roux-en-Y Gastric Bypass Impact Adverse Operative Outcomes? Obes Surg.
Stephanie Wood MD, Sandhya Kumar B, Elizabeth Dewey MD, Matthew MS, Lin Y, Jonathan T, Carter MD (2019) Safety of concomitant cholecystectomy with laparoscopic sleeve gastrectomy and gastric bypass: a MBSAQIP analysis. Obes Surg 15(6):864–870
doi: 10.1016/j.soard.2019.03.004
Bailey JG, Hayden JA, Davis PJ, Liu RY, Haardt D, Ellsmere J (2014) Robotic versus laparoscopic Roux-en-Y gastric bypass (RYGB) in obese adults ages 18 to 65 years: a systematic review and economic analysis. Surg. Endosc 28(2):414–426
doi: 10.1007/s00464-013-3217-8
. Papasavas P, Seip RL, Stone A, Staff I, McLaughlin T, Tishler D. (2019) Robot-assisted Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: Results from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Data Registry. Surgery for Obesity and Related Diseases.
Sharma G, Strong AT, Tu C, Brethauer SA, Schauer PR, Aminian A (2018) Robotic platform for gastric bypass is associated with more resource utilization: an analysis of MBSAQIP dataset. Surgery for Obesity and Related Diseases 14(3):304–310
doi: 10.1016/j.soard.2017.11.018
Strosberg DS, Nguyen MC, Peter Muscarella II, Narula VK (2017) A retropective comparison of robotic cholecystectomy versus laparoscopic cholecystectomy: operative outcomes and cost analysis. Surg Endosc 31(3):1436–1441
doi: 10.1007/s00464-016-5134-0
Pokala B, Flores L, Armijo PR, Kothari V, Oleynikov D (2019) Robot-assisted cholecystectomy is a safe but costly approach: A national database review. Am J Surg 218(6):1213–1218
doi: 10.1016/j.amjsurg.2019.08.014
Wanjura V, Szabo E, Osterberg J, Ottosson J, Enochsson L, Sandblom G (2018) Morbidity of cholecystectomy and gastric bypass in a national database. Br J Surg, pp. 121–127.
Patel JA, Patel NA, Piper G, Smith D, Malhotra G, Colella J (2009) Perioperative Management of Cholelithiasis in Patiens Presenting for Laparscopic Roux-en-Y Gastric Bypass: Have we Reached a Consensus? The American Surgeon 75(6):470–476
doi: 10.1177/000313480907500604
Pineda O, Maydon H, Amado M, Sepulveda E, Guillbert L, Espinosa O, Zerrweck C (2017) A prospective study of the conservative management of asymptomatic preoperative and postoperative gallbladder disease in bariatric surgery. Obes Surg 27:148–153
doi: 10.1007/s11695-016-2264-3
Hamad GG, Ikramuddin S, Gourash WF et al (2003) Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg 13(1):76–81
doi: 10.1381/096089203321136638
Villegas L, Schneider B, Provost D et al (2004) Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg 14:60–66
doi: 10.1381/096089204772787301
Swartz DE, Felix EL (2005) Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis. 1:555–560
doi: 10.1016/j.soard.2005.08.002
Patel KR, White SC, Tejirian T et al (2006) Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatement are not necessary. Am Surg 72:857–861
doi: 10.1177/000313480607201003
Papasavas PK, Gagne DJ, Ceppa FA et al (2006) Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2:41–46
doi: 10.1016/j.soard.2005.10.006
Puzziferri N, Austrheim-Smith IT, Wolfe B, Wilson SE, Nguyen NT (2006) Three-year Follow-up of a Prospective Randomized Trial Comparing Laparoscopic Versus Open Gastric Bypass. Ann Surg 243:181–188
doi: 10.1097/01.sla.0000197381.01214.76
Fuller W, Rasmussen JJ, Ghosh J et al (2007) Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg 17:747–751
doi: 10.1007/s11695-007-9138-7
Portenier DD, Grant JP, Blackwood HS et al (2007) Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 3:476–479
doi: 10.1016/j.soard.2007.02.006
Tucker O, Soriano I, Szomstein S et al (2008) Management of choledocholithiasis after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 4:674–678
doi: 10.1016/j.soard.2008.01.014
Kim JJ, Schirmer B (2009) Safety and eficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 5:48–53
doi: 10.1016/j.soard.2008.06.001
D’Hondt M, Sergant G, Deylgat B et al (2011) Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg 15:1532–1536
doi: 10.1007/s11605-011-1617-4
Tarantino I, Warschkow R, Steffen T et al (2011) Is routine cholecystectomy justified in severely obese partients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg 21:1870–1878
doi: 10.1007/s11695-011-0495-x
Altieri MS, Yang J, Nie L, Docimo S, Talamini M, Pryor AD (2018) Incidence of Cholecystectomy after Bariatric Surgery. Surg Obes Relat Dis 14:992–996
doi: 10.1016/j.soard.2018.03.028